Assessing Functional Similarity of Biosimilar ABP 654 and Ustekinumab in Samples from Patients with Crohn’s Disease

Assessing Functional Similarity of Biosimilar ABP 654 and Ustekinumab in Samples from Patients with Crohn’s Disease

Ian N Foltz,1 Kevin Gaida,2 Helen Y Wong,1 Michael Ng,1 Marijana Busch,1 Jennifer L Liu3 1Amgen Research, Department of Therapeutic Discovery, Amgen Inc., Burnaby, BC, V5A1V7, Canada; 2Research and Development, Amgen Inc., Thousand Oaks, CA, 91320, USA; 3Biosimilar Process Development, Amgen Inc., T...

Full description

Saved in:
Bibliographic Details
Main Authors: Foltz IN, Gaida K, Wong HY, Ng M, Busch M, Liu JL
Format: Article
Language:English
Published: Dove Medical Press 2024-12-01
Series:Journal of Inflammation Research
Subjects:
abp 654
biosimilar pharmaceuticals
crohn’s disease
interleukin-12
interleukin-23
interchangeable
Online Access:https://www.dovepress.com/assessing-functional-similarity-of-biosimilar-abp-654-and-ustekinumab--peer-reviewed-fulltext-article-JIR
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.dovepress.com/assessing-functional-similarity-of-biosimilar-abp-654-and-ustekinumab--peer-reviewed-fulltext-article-JIR

Similar Items